TcpC Inhibits Neutrophil Extracellular Trap Formation by Enhancing Ubiquitination Mediated Degradation of Peptidylarginine Deiminase 4

Qian Ou,Jia-qi Fang,Zhe-sheng Zhang,Zhe Chi,Jie Fang,Di-yan Xu,Kai-zhong Lu,Meng-qing Qian,Da-yong Zhang,Jun-ping Guo,Wei Gao,Na-ru Zhang,Jian-ping Pan
DOI: https://doi.org/10.1038/s41467-021-23881-8
IF: 16.6
2021-01-01
Nature Communications
Abstract:TcpC is a multifunctional virulence factor of uropathogenic E. coli (UPEC). Neutrophil extracellular trap formation (NETosis) is a crucial anti-infection mechanism of neutrophils. Here we show the influence of TcpC on NETosis and related mechanisms. We show NETosis in the context of a pyelonephritis mouse model induced by TcpC-secreting wild-type E. coli CFT073 (CFT073wt) and LPS-induced in vitro NETosis with CFT073wt or recombinant TcpC (rTcpC)-treated neutrophils are inhibited. rTcpC enters neutrophils through caveolin-mediated endocytosis and inhibits LPS-induced production of ROS, proinflammatory cytokines and protein but not mRNA levels of peptidylarginine deiminase 4 (PAD4). rTcpC treatment enhances PAD4 ubiquitination and accumulation in proteasomes. Moreover, in vitro ubiquitination kit analyses show that TcpC is a PAD4-targetd E3 ubiquitin-ligase. These data suggest that TcpC inhibits NETosis primarily by serving as an E3 ligase that promotes degradation of PAD4. Our findings provide a novel mechanism underlying TcpC-mediated innate immune evasion.
What problem does this paper attempt to address?